IP Library Granted Patent US 11,344,652
Granted Patent B2
US 11,344,652 · App. 16/566,522 · Granted May 31, 2022

Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices

Inventors: Robert Kellar (Flagstaff, AZ); Nathan Christopher Nieto (Flagstaff, AZ); Andrew Koppisch (Flagstaff, AZ); Rico Del Sesto (St. George, UT)
Assignees: THE ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY; DIXIE STATE UNIVERSITY
A61L26/0038A61K9/0014A61K31/14A61K31/20A61K38/39A61L15/32A61L15/44A61L26/0033A61L26/0042D01D5/003D01F1/103A61L2300/404D01D5/0015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,344,652
App. No.
16/566,522
Granted
May 31, 2022
Kind
B2
Abstract

Compositions for enhancing wound healing are disclosed herein. Also disclosed are methods of making the compositions and methods of using the compositions for the prevention of biofilm formation and for the inhibition of pathogen growth and proliferation.

Claims (20)

1. An electrospun wound care composition, comprising:

an ionic liquid (IL) comprising choline geranate and a neutral species comprising farnesol, wherein the ionic liquid is present in an amount of about 0.01% w/w to about 99% w/w; and

a protein solution comprising extracellular matrix protein,

wherein the IL is electrospun with the protein solution.

2. The wound care composition of claim 1 , wherein the IL further comprises choline citronellate.

3. The wound care composition of claim 1 , wherein the wound care composition is incorporated with or impregnated into or coated onto a wound dressing, a bandage, a gauze, a patch, a pad, tape, or a wrap.

4. The wound care composition of claim 1 , wherein the ionic liquid is present in an amount of about 40% w/w.

5. The wound care composition of claim 1 , wherein the protein solution further comprises collagen, albumin, casein, fibrin, fibroin, gelatin, keratin, elastin, tropoelastin, or combinations thereof.

6. The wound care composition of claim 1 , wherein the protein solution is present in an amount of about 1% w/v to about 20% w/v.

7. The wound care composition of claim 1 , wherein the protein solution is present in an amount of about 10% w/v.

8. The wound care composition of claim 1 , comprising IL in an amount of about 0.2% w/w and wherein the protein solution comprises extracellular matrix protein in an amount of about 10% w/v.

9. The wound care composition of claim 1 , wherein the neutral species further comprises linalool, carvacrol, geranic acid, citronellic acid, cinnamaldehyde, eugenol, or combinations thereof.

10. The wound care composition of claim 1 , further comprising an antibiotic, a steroid, an analgesic, a cannabinoid, a growth factor, or a combination thereof.

11. A wound dressing comprising:

an electrospun wound care composition of claim 1 ; and

a wound dressing material.

12. The wound dressing of claim 11 , wherein the wound dressing material is a bandage, a wipe, a sponge, a mesh, a dressing, a gauze, a patch, a pad, tape, or a wrap.

13. The wound dressing of claim 11 , wherein the wound care composition is present in an amount of about 0.005% v/w to about 2% v/w.

14. The wound dressing of claim 11 , wherein the wound care composition is present in an amount of about 0.625% v/w.

15. The wound dressing of claim 11 , wherein the wound care composition is incorporated into or coated onto or impregnated with the wound dressing material.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2022
From: DEL SESTO, RICO
To: DIXIE STATE UNIVERSITY
Reel/Frame 059917/0621 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2022
From: KELLAR, ROBERT S.; KOPPISCH, ANDREW T.; NIETO, NATHAN C.
To: ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY
Reel/Frame 059505/0395 →
Continuity (4)
Continuation In Part 16368038 · Mar 28, 2019
Continuation 15725213 · Oct 4, 2017
Provisional Application 62404369 · Oct 5, 2016
Related Publication 20200000960A1 · Jan 2, 2020
Cited By (1)
US 12,208,069